Effect of Low-Dose Versus Standard-Dose Ticagrelor and Clopidogrel on Platelet Inhibition in Acute Coronary Syndromes

J Am Coll Cardiol. 2018 Apr 10;71(14):1594-1595. doi: 10.1016/j.jacc.2018.02.010.

Authors

Duk-Woo Park, Pil Hyung Lee, Seongsoo Jang, Hyeong-Seok Lim, Do-Yoon Kang, Cheol Hyun Lee, Jung-Min Ahn, Sung-Cheol Yun, Seong-Wook Park, Seung-Jung Park

PMID: 29622168
DOI: 10.1016/j.jacc.2018.02.010

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Acute Coronary Syndrome / drug therapy*
Acute Coronary Syndrome / metabolism
Clopidogrel / administration & dosage*
Clopidogrel / pharmacokinetics
Dose-Response Relationship, Drug
Drug Therapy, Combination
Humans
Platelet Aggregation Inhibitors / administration & dosage
Purinergic P2Y Receptor Antagonists / administration & dosage
Ticagrelor / administration & dosage*
Ticagrelor / pharmacokinetics
Treatment Outcome

Substances

Platelet Aggregation Inhibitors
Purinergic P2Y Receptor Antagonists
Clopidogrel
Ticagrelor

Associated data

ClinicalTrials.gov/NCT02319941